EP Patent

EP0941102A1 — Compositions for the treatment of gastrointestinal disorders containing bismuth and nsaid

Assigned to Procter and Gamble Co · Expires 1999-09-15 · 27y expired

What this patent protects

The present invention relates to methods and compositions for treating a gastrointestinal disorder caused or mediated by Helicobacter pylori comprising bismuth, and a gastropathic amount of a non-steroidal anti-inflammatory drug. The inventions may further comprise therapeuticall…

USPTO Abstract

The present invention relates to methods and compositions for treating a gastrointestinal disorder caused or mediated by Helicobacter pylori comprising bismuth, and a gastropathic amount of a non-steroidal anti-inflammatory drug. The inventions may further comprise therapeutically effective amounts of one or more anti-secretory drugs.

Drugs covered by this patent

Patent Metadata

Patent number
EP0941102A1
Jurisdiction
EP
Classification
—
Expires
1999-09-15
Drug substance claim
No
Drug product claim
No
Assignee
Procter and Gamble Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.